Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo
about
Low expression of microRNA-202 is associated with the metastasis of esophageal squamous cell carcinomaMicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency.MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4.Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinomaMolecular interplay of pro-inflammatory transcription factors and non-coding RNAs in esophageal squamous cell carcinoma.MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation.Function and regulation of microRNA-31 in development and disease.STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1.New strategies in esophageal carcinoma: promises and problems.Identification of aminosulfonylarylisoxazole as microRNA-31 regulators.Zinc intake, microRNA dysregulation, and esophageal cancer.Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinoma.Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia.Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.The major miR-31 target genes STK40 and LATS2 and their implications in the regulation of keratinocyte growth and hair differentiation.LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers.
P2860
Q36639927-2B16F6EC-99DE-4937-81AC-53C4C4182CA2Q36998078-514BDF68-CA50-42F7-9607-A202A47884E6Q37318171-75B7109F-0204-47E8-8258-496A34FC7BA6Q37527769-0C96FA22-5A15-4176-A180-A45395B9D4E5Q38670580-C19237C0-2E3F-4536-A7C7-FF40B15A45CFQ38749995-935299D7-ADF3-4C77-B8D6-759B7AA1AA5BQ38769734-A9FAC2BD-ED86-4D89-BE38-8EF8622B466CQ38893973-A29EF357-8C93-46D8-A9DF-2559558DBD1DQ39019704-735DC9D5-183B-4B6F-8F83-90FC27AAD0E6Q39717218-C3097261-0CA4-4F03-9C84-9111EC542FB3Q41255588-3158872B-89E2-4DCE-9CCF-5CA30BCE4C4AQ42433818-1B208019-52E0-4A5C-B65C-C0526D5DDD9CQ44089610-EA5C4283-B345-4ADE-99E9-108EEADE7508Q46586656-0C96A7DD-FCFD-401E-B0FD-0B4A51E1CCBAQ47571295-0E4B1BA3-5A0D-4282-B545-FE0564F1524CQ48263799-6F4DF214-1F6A-4C12-A026-0CC2D123CBB5Q54977482-62EFC0B7-E7E9-4ABC-9581-40BCBCA73A9B
P2860
Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Repression of Esophageal Neopl ...... y Anti-miR-31 Delivery In Vivo
@ast
Repression of Esophageal Neopl ...... y Anti-miR-31 Delivery In Vivo
@en
type
label
Repression of Esophageal Neopl ...... y Anti-miR-31 Delivery In Vivo
@ast
Repression of Esophageal Neopl ...... y Anti-miR-31 Delivery In Vivo
@en
prefLabel
Repression of Esophageal Neopl ...... y Anti-miR-31 Delivery In Vivo
@ast
Repression of Esophageal Neopl ...... y Anti-miR-31 Delivery In Vivo
@en
P2093
P2860
P356
P1476
Repression of Esophageal Neopl ...... y Anti-miR-31 Delivery In Vivo
@en
P2093
Cristian Taccioli
Gianpiero Di Leva
Guidantonio Malagoli Tagliazucchi
Hansjuerg Alder
Hongping Chen
John L Farber
Justin Middleton
Karl J Smalley
Louise Y Fong
Michela Garofalo
P2860
P356
10.1093/JNCI/DJV220
P407
P577
2015-08-18T00:00:00Z